Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
Objective: Neoantigens arising from gene mutations in tumors can induce specific immune responses, and neoantigen-based immunotherapies have been tested in clinical trials. Here, we characterized the efficacy of altered neoepitopes in improving immunogenicity against gastric cancer. Methods: Raw dat...
Enregistré dans:
Auteurs principaux: | Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li, Yunbin Ye |
---|---|
Format: | article |
Langue: | EN |
Publié: |
China Anti-Cancer Association
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/12347c1122474a80bf017005f30ba371 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer
par: Jianming Wei, et autres
Publié: (2021) -
Bioinformatics Analysis of Hub Genes and Potential Therapeutic Agents Associated with Gastric Cancer
par: Zhang S, et autres
Publié: (2021) -
Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation
par: Xiaodong Wang, et autres
Publié: (2021) -
LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis
par: Wei Yang, et autres
Publié: (2021) -
Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer
par: Jin L, et autres
Publié: (2021)